Sun Pharma UractivTM Portfolio Fiterman Pharma Romania
Drug Updates

Sun Pharma acquires UractivTM portfolio from Fiterman Pharma in Romania

Sun Pharmaceutical Industries Limited has announced that one of their subsidiaries, SC Terapia SA, Romania has acquired the UractivTM portfolio from Fiterman Pharma again in Romania. The UractivTM portfolio comprises food supplements including minerals, vitamins and adjuvants; cosmetics and medical devices used for maintaining urinary tract health.

     UractivTM is a popular brand in Romania. It is trusted by consumers for more than 10 years. The portfolio involving 12 SKUs has annualized revenues of approximately of US$ 8.7 million. The products cater to both adults and children. Aalok Shangvi, EVP & Head-Generic R&D, Generic Global BD and Emerging Markets of Sun Pharma said, “We are excited to add UractivTM to our consumer healthcare portfolio in Romania. This acquisition is in line with our strategy to further expand non-prescription product basket in Romania and neighboring markets”.

   He also added that, they have a strong presence in Romania with Terapia being the number one company in the genetics and OTC market. They will leverage their robust marketing and distribution strengths to grow these brands further. The acquisition is subject to customary closing conditions and regulatory approvals. Financial terms of the transaction are confidential.

For more information visit:


Leave a Reply

Your email address will not be published. Required fields are marked *